Clinical Trials
FDA Approves Vismodegib For Advanced Basal Cell Carcinoma
Currently Recruiting Trials
Psoriasis Trials
Sponsored by Pfizer, 2 trials currently running for moderate - severe psoriasis using a drug named Tofacitinib which is a JAK inhibitor. Recruitment closed
Sponsored by Amgen, 1 trial currently running for moderate - severe psoriasis, drug named AMG827 which is an anti interleukin 17 receptor monoclonal antibody. Recruitment closed.
Sponsored by Amgen, for moderate to severe psoriasis, drug named AMG827 which is an anti interleukin 17 receptor monoclonal antibody. Recruiting at present.
Actinic Kerotosis
Sponsored by Galderma, looking at difference in treatments of PVT and daylight with the use of Metvix. Recruiting at present.
Clinical Trials we have conducted
Sponsored by Anacor, for mild to moderate atopic dermatitis, comparing the treatments on AN2898 1% and AN2728 2%
Sponsored by Regeneron, for moderate to severe atopic dermatitis, using a monoclonal antibody that is directed against IL4 receptor alpha.
1990 Interpro, Inc. "Evaluation of Dermaffin in the Treatment of Psoriasis"
Design, conduct & analysis of RCT comparing dermaffin cream vs 0.1% triamcinolone cream vs Eucerin Cream vs no treatment in chronic plaque psoriasis - PI driven study at University of North Carolina, Chapel Hill.
1998 Schering-Plough Pharmaceuticals ? Dept Derm, St George Hospital, Sydney
"A Randomized Trial of Elocon versus Advantan in Psoriasis"
1998 3M Pharmaceuticals
"Imiquimod for the treatment of Superficial and Nodular Basal Cell Carcinomas"
1999 Scotia Pharmaceuticals -
Trentinoin in Galactobase for Acne
2000 Biotech Australia -
Principal Investigator: Psoriasis Study
2000 Photocure (Norway) -
Principal Investigator: Metvix Photodynamic Therapy for Actinic Keratoses
2000 Photocure -
Principal Investigator: Metvix Photodynamic Therapy for High Risk Basal Cell Carcinoma
2000 A randomized trial of Treatment Efficiancy and Relapse Rates of Acne Vulgaris treated with Isotretinoin to 120mg//kg/day (PI- study driven) Grant from Roche
2000 Photocure -
Principal Investigator: Metvix Photodynamic Therapy for Nodular Basal Cell Carcinoma
2001 - 02 Novartis -
Principal Investigator: SDZ-ASM 981 double-blind placebo controlled multicentre dose-finding study in chronic plaque psoriasis
2004 Serono:
PFP for Efalizumab for Psoriasis.
2004 Fujisawa
Principal Investigator: A double bind, multicentre randomized, parallel group study to demonstrate the equivalence of the response to vaccination of a tacrolimus ointment regimen to a steroid ointment regimen in children with moderate to severe atopic dermatitis
2004 GlaxoSmith Kline
Principal Investigator: A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Safety and Efficacy of Three Dose Levels of Rosiglitazone Maleate in the Treatment of Chronic Plaque Psoriasis.
2005 Galderma:
A randomized trial of Metvix PDT versus excisional surgery for nodular basal cell carcinoma.
2005 Molynlycke, Sweden:
Sponsorship of dressings for trial of mepilex and mepilex lite vs mepitel in epidermolysis bullosa
2005 Galderma:
A randomized trial of Metvix PDT versus excisional surgery for superficial basal cell carcinoma.
2006 Novartis:
A randomized controlled trial of Elidel Cream for Facial Atopic Dermatitis.
2005 Clinical Cell Culture, C3, Perth:
Donation of Recell kits for one arm of RCT of cosmetic treatments for vitiligo
2005 Stiefel Laboratories:
Donation towards dermabrader needed for RCT of cosmetic treatments for chronic stable vitiligo.
2006/07 Galderma:
A phase II randomized controlled trial of CD5024 cream for rosacea and follow-on study
2007-08 Cell therapy trial for RDEB.
2007 Schering Plough:
PFP for infliximab for psoriasis.
